FGH Biotech is committed to developing molecules For Good Health that control SREBP transcription factors and related pathways for the prevention and treatment of metabolic diseases.

Our mission is driven by over 60 years of groundbreaking discoveries in fat and energy metabolism by our company’s founders.

Learn more about Metabolic Diseases